Financial News

BMS sees year-on-year earnings increase of nearly $60 million in Q2

Jul 23, 2008

The anti-blood clot drug Plavix and the schizophrenia drug Abilify helped...

Eli Lilly posts increased 2Q profits

Jul 23, 2008

Eli Lilly’s second-quarter profits increased thanks to prescription drug...

Genzyme may delay production plans for Myozyme

Jul 23, 2008

Genzyme said Wednesday that its plans to boost production of the drug...

GSK posts 2Q results, sees increased sales

Jul 23, 2008

GlaxoSmithKline’s second quarter was weak on reports that the company’s...

Pfizer records high earnings despite problems with antismoking drug

Jul 23, 2008

Pfizer released its second earnings report and despite the lost of more...

Schering-Plough reports strong Q2 sales growth

Jul 23, 2008

A growth and diversification strategy that started in 2003 has produced...

Wyeth's 2Q sales rise, but income sees decline

Jul 23, 2008

Wyeth announced that its net income declined by 6 percent to $1.12 billion...

SPECIAL REPORTS

Top 100 Niche Brands 2013

Success in the mass market can be an uphill battle for some niche brands as retailers trim selection, bolster private-label offerings and pass on smaller brands they perceive as higher risk. However, retailers also are increasingly looking to distinguish themselves from the competition, whether it is through exclusive offerings, customization or in-store services. To gain greater insight, Drug Store News once again hosted a virtual roundtable discussion with some of today’s leading players.

REGIONAL CHAIN REPORT

The Locals: Regional chains on the express track

Even as the big chains get bigger, the industry's top regional chains continue...

POWERx PLAYERS: DSN ANNUAL REPORT 2013

The DSN PoweRx Players ranks the Top 50 kings of pharmacy — including drug chains, independents, supermarkets, mass and club stores — by the one metric that matters: pharmacy sales. This year's rankings also include the top Canadian pharmacy chains. Click here for the full report.